Endpoints News 11 may 2026 New home for Novo's Parkinson's cell therapy; GSK turns to China for hep B drug
FierceBiotech 11 may 2026 Amid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase data
FierceBiotech 11 may 2026 Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan
Lonza News 11 may 2026 Lonza says big pharma might delay outsourcing decisions amid US investments - MSN
Merck & Co. 11 may 2026 Merck makes a new move in Astra battle | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Merck & Co. 11 may 2026 Amid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase data - Fierce Biotech
PLoS Biology 11 may 2026 The problem with one-size-fits-all medicine: Biological sex and the aging immune system
PLoS Biology 11 may 2026 USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STING
BioPharma Dive 11 may 2026 Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
Charles River 11 may 2026 Charles River Laboratories Introduces AI-Powered, End-to-End Workflow - Contract Pharma